Current models of stem cell biology assume that normal and neoplastic stem cells reside at the apices of hierarchies and differentiate into nonstem progeny in a unidirectional manner. Here we identify a subpopulation of basal-like human mammary epithelial cells that departs from that assumption, spontaneously dedifferentiating into stem-like cells. Moreover, oncogenic transformation enhances the spontaneous conversion, so that nonstem cancer cells give rise to cancer stem cell (CSC)-like cells in vitro and in vivo. We further show that the differentiation state of normal cells-of-origin is a strong determinant of posttransformation behavior. These findings demonstrate that normal and CSC-like cells can arise de novo from more differentiated cell types and that hierarchical models of mammary stem cell biology should encompass bidirectional interconversions between stem and nonstem compartments. The observed plasticity may allow derivation of patient-specific adult stem cells without genetic manipulation and holds important implications for therapeutic strategies to eradicate cancer.
breast cancer | dedifferentiation T issue-specific stem cells exist in many adult tissues and can be identified and isolated using specific antigen profiles. Their potential utility in regenerative medicine holds great promise. However, our current ability to isolate and propagate adult stem cells for such purposes is limited (1) . This limitation is due in part to the paucity of stem cells in most epithelial tissues and our fragmentary understanding of the survival, proliferation, and differentiation signals that these cells receive in highly specialized stem-cell niches (2, 3) .
The discovery of stem-like cells in a number of human solid tumor types has suggested a central role for stem cells in tumorigenesis. Thus, stem-like cells, often termed cancer stem cells (CSCs), have been defined experimentally by their ability to seed new tumors and to spawn non-CSC populations lacking tumorinitiating ability. CSC subpopulations have now been identified in a variety of malignancies (4) . Importantly, CSC-rich tumors are associated with aggressive disease and poor prognosis (5) , indicating that an understanding of their biology is pertinent to developing effective therapies.
Both normal and neoplastic stem cells are thought to be selfrenewing and to reside at the apex of a cellular hierarchy. Through asymmetric division, these stem cells generate more differentiated progeny that lack self-renewal capacity (6, 7) . Intratumor heterogeneity may thus derive from neoplastic cells at various differentiation stages. In the case of human mammary epithelial cells (HMECs), the structure of the associated stem-cell hierarchy is yet to be definitively described. It is becoming apparent, however, that the differentiation states of cells-of-origin can influence the organization of derived neoplastic cell populations (8, 9) .
These hypotheses have been difficult to validate because of the apparent critical role of the stem-cell niche and associated microenvironment in the survival and differentiation of both normal and neoplastic stem cells. However, evidence of normal and neoplastic cells with stem-cell properties residing naturally among populations of epithelial cells propagated in culture has been reported (10) (11) (12) .
In light of the latter observations, we undertook to study the biology of subpopulations of HMECs that exist in culture and share certain properties with either stem-like cells or their more differentiated derivatives. We identified an unexpected degree of plasticity between stem-like and nonstem cell compartments, leading to the demonstration that differentiated cell types can convert to stem-like cells. Moreover, these observations hold true for the neoplastic counterparts of such cells.
Results

Enrichment of a Rare Floating Population of Cells from Cultured
Human Mammary Epithelial Cells. In the work described below we used primary HMECs as well as HMECs immortalized with human telomerase (hTERT) that are termed here HME cells (13, 14) . We observed that populations of HME cells cultured in their normal mammary epithelial growth medium contained a small proportion of cells that grew as floating cells above the majority population of adherent cells. These populations, termed here HME-floating population of cells (HME-flopcs), were collected from the conditioned media of HME cells through centrifugation and introduced into new culture dishes, yielding fully viable, adherent cell populations.
The epithelial nature of HME and HME-flopc cells was confirmed by the expression of cytokeratins and low vimentin expression (Fig. 1C) and by formation of acinar structures when plated at clonal density on a layer of Matrigel (15) . These polarized epithelial structures contained cells expressing vimentin, cytokeratins, and MUC1, the latter marking luminal epithelial cells in the mammary gland (Fig. S1C) . However, under twodimensional (2D) culture conditions, HME cells formed a typical epithelial monolayer with junctional E-cadherin, β-catenin, and ZO-1, whereas HME-flopc cells did not, despite similarly high levels of those proteins ( Fig. 1 B and C) . Thus, HME-flopc cells were stably morphologically distinct from the bulk HME cells. hi CD24 lo ESA − cells we determined that HME-flopc cells are enriched for a putative stem-like fraction over HME cells (2.5% vs. 0.2%, respectively) (Fig. 1D) .
We also analyzed the CD44 lo CD24 + nonstem cell fractions of HME and HME-flopc cells and found HME CD44 lo CD24 + cells were ∼51% ESA + and 49% ESA − cells, whereas HME-flopc CD44 lo CD24 + cells were 96% ESA − (Fig. 1D ). Together these results indicated the presence of three major subtypes of cells coexisting within HME cultures, which we have designated as follows ( Fig. 1A) 
ESA
− antigen profile). The flopc isolation method enriched for the latter two cell populations. Importantly, HME-flopc-CD44 hi cells bear a marker profile similar to mammary progenitor/stem cells and HME-CD44 lo cells and HME-flopc-CD44 lo cells bear marker profiles of more differentiated cell populations.
HME-flopc-CD44
lo Cells Spontaneously Convert into CD44
hi Cells. We explored the biological properties of the two major cell types that constitute the HME-flopc population: the HME-flopc-CD44 hi putative stem-like fraction and the nonstem HME-flopc-CD44 lo fraction. We purified these cell types through single-cell cloning yielding seven single-cell clones (SCCs) that were stably CD44 hi and 28 SCCs that were predominantly CD44 lo . The latter CD44 lo SCCs also contained a small component of CD44 hi cells (ranging from 1 to 10% of the population) ( Fig. S1 and data not shown). This result provided the first indication that one population of cells (HME-flopc-CD44 lo ) can give rise to the other (HME-flopc-CD44 hi ). To further explore this notion, we fractionated two HME-flopc-CD44 lo SCC populations (termed FL1 and FL2, where "L" designates that the clones are predominantly CD44 lo ) (Fig. 1A and Fig. S1E ) into CD44 hi and CD44 lo subpopulations by FACS, introduced the purified populations into 2D culture, and monitored them by FACS over the subsequent 12 d. Purified HME-flopc-CD44 hi cells did not regenerate the HME-flopc-CD44 lo cell subpopulation and remained as pure CD44 hi populations (data not shown). However, the HME-flopc-CD44 lo cultures developed a progressively increasing CD44 hi subpopulation ( Fig. 2 A and C). The observed increase in CD44 hi cells in these cultures was compatible with either of two mechanisms: the initial CD44 lo cells spontaneously dedifferentiated into CD44 hi cells or the emerging population of CD44 hi cells grew out from CD44 hi cells that had contaminated the purified CD44 lo population following the initial FACS. In fact, the proliferation rates of the two cell populations (and of second-generation CD44 hi cells repurified from HMEflopc-CD44 lo cells) were not significantly different (Fig. 2B) . Moreover, in a reconstructed heterogeneous population, in which we mixed purified CD44 hi cells expressing the tomato fluorescent protein (CD44 hi -Tom) with purified, unlabeled HME-flopc-CD44 lo cells, the percentage of CD44 hi -Tom cells decreased progressively from 15 to 5% over 12 d (Fig. 2E ). This result demonstrated directly that the CD44 hi cells actually proliferated more slowly than HME-flopc-CD44 lo cells in a mixed cell population. Together these results indicated that the emerging CD44 hi cells could not have arisen from a contaminating CD44
hi subpopulation that outgrew the majority CD44 lo cell population. We thus concluded that HME-flopc-CD44 lo cells spontaneously generated CD44
hi cells in 2D cultures. Interestingly, the presence of admixed CD44 hi -Tom cells (Fig.  2E ) did not inhibit the de novo generation of CD44 hi cells arising from the unlabeled HME-flopc-CD44 lo cells, arguing against some type of homeostatic control of CD44 hi cell number under these culture conditions.
We repeated the same time-course experiment with purified populations of HME-CD44 hi and HME-CD44 lo cells fractionated by FACS directly from parental HME cells. Unlike HMEflopc-CD44 lo cells, HME-CD44 lo cells were poorly able to generate CD44 hi cells in vitro (Fig. 2C ).
Display of Mammary Progenitor Traits by Preexisting and de NovoGenerated CD44
hi Cells. We used the in vitro mammosphereforming assay (17) to acquire functional evidence that de novoderived and preexisting HME-flopc-CD44 hi cells were enriched for cells with mammary stem-like traits. Cells were plated as single cells at a density of 300 cells/well (96-well plate). Bulk HME cells did not form any detectable mammospheres, demonstrating that the stem-like fraction represented <1 in 2,000 cells in this population. In contrast, bulk HME-flopc cells and HME-flopc-CD44
lo SCCs (n = 3) formed mammospheres at a frequency of 1.2/300 cells and 0.4/300 cells, respectively (Fig.  3A) . Stable HME-flopc-CD44
hi SCCs formed mammospheres at the highest rate (2.3/300 cells) (Fig. 3A) , indicating that mammosphere formation correlates with CD44 hi expression. Because HME-flopc-CD44
lo SCCs inevitably contained subpopulations of CD44 hi cells (Fig. S1E) , we purified CD44 lo and CD44
hi fractions by FACS and demonstrated that CD44 lo cells did not form mammospheres, whereas CD44 hi cells formed mammospheres quite efficiently (∼1.5/300 cells) (Fig. 3A) . These results indicated that (i) mammosphere formation is largely if not entirely restricted to CD44 hi cells and (ii) both preexisting CD44 hi cells (HME-flopc-CD44 hi SCCs) and de novo arising CD44 hi cells (arising from HME-flopc-CD44 lo cells) display mammosphereforming ability. Whereas HME-flopc-CD44 hi stem-like cells did not give rise to more differentiated progeny in 2D culture (Fig. S1) , we reasoned that the 3D mammosphere culture envi- (Fig. 3D) . Hence, 3D but not 2D culture conditions permitted the conversion of the various CD44 hi cells into at least two types of more differentiated derivatives. Moreover, in the case of de novo-derived CD44 hi cells, 3D culture conditions were able to reverse the process that led to their recent de novo formation in 2D culture.
By gene set enrichment analysis (18) we compared the gene expression profiles of cultured HME-flopc-CD44 hi mammary stem-like cells to those of primary human mammary stem-like cells (19) . HME-flopc-CD44 hi cells were enriched in both bipotent progenitor cell and luminal progenitor cell gene expression signatures compared with bulk HME-flopc cells (Fig. S1D) , indicating that HME-flopc-CD44 hi cells are enriched in a gene signature that resembles that of primary human mammary progenitor cells. We used the humanized mouse mammary fat pad reconstitution assay (20) to test for human stem cell activity by assessing a cell's ability to generate mammary structures in a humanized murine fat pad of NOD/SCID mice. We implanted a variety of cell populations (2 × 10 5 cell aliquots): (i) parental unfractionated HME cells, (ii) preexisting pure HME-flopc-CD44 hi cells (clone FH1, Fig. 1A ), (iii) spontaneously arising CD44 hi cells purified by FACS from HME-flopc SCC FL1, and (iv) uncultured, single-cell suspensions of freshly isolated HMECs (which served as a positive control).
At 12 wk, ductal structures arose from the uncultured HMECs as well as from both FH1 and FL1-CD44 hi cells, whereas HME cells gave rise only to cell aggregates and simple cystic structures. The ductal structures arising from FH1, FL1-CD44 hi , and uncultured HMECs were composed of stratified epithelium that stained for keratin-14 in the basal layer and pan-cytokeratin in the luminal layer (Fig. 4A) . The human origin of the ductal structures was confirmed by the expression of pLV-Tomato using fluorescent microscopy of whole-mount mammary fat pads (Fig.  S2A) . By this stringent measure, de novo-derived and preexisting Mammosphereforming ability of bulk HME or HME-flopc cells, HME-flopc-CD44 lo single-cell clones (SCCs, n = 5), HME-flopc-CD44
hi SCCs (n = 4), and CD44 hi and CD44 lo cells purified by FACS from two independent HME-flopc SCCs (FL1 and FL2 To demonstrate that cells similar to the three subpopulations of mammary epithelial cells identified in cultured HME cells (Fig.  1A ) mirrored cell types that exist in vivo in the normal human mammary gland, we analyzed uncultured primary HMECs for CD44, CD24, and ESA expression ( Fig. S6 and SI Materials and Methods). We also analyzed other commonly used markers (9, 21) on cultured HMECS to further identify HMEC subpopulations (Fig. S2B) − basal cell population (equivalent to HME-flopc-CD44 lo cells). In uncultured HMECs, the basal cell population was on average 3.3 times more abundant than the luminal fraction (Fig. 4B) . The ploidy of all cells was checked (Fig. S3) . Hence HME and HME-flopc populations likely have biological equivalents in primary normal human mammary breast tissue.
We next sought to demonstrate that freshly isolated primary basal HMECs (equivalent to HME-flopc-CD44 lo cells) could spontaneously convert to the CD44 hi CD24 lo ESA − mammary stem cell fraction), P2 (basal population), and P3 (luminal population) in cultured HMECs were on average 0.3%, 62%, and 38%, respectively.
Indeed, primary basal cells converted to the CD44 hi -CD24 lo ESA − progenitor/stem-like state (which represented 6% of the population by day 12). As also predicted from our earlier studies, primary luminal cells poorly converted into the progenitor/stem-like state (Fig. 4D ). These results demonstrate that primary mammary basal epithelial cells can spontaneously generate progenitor, if not stem-like, cells in 2D culture.
Transformed Epithelial Cells Spontaneously Generate Cancer StemLike Cells. We next wanted to determine whether the oncogenic counterparts of HME-flopc-CD44 lo cells could also undergo spontaneous conversion. If so, we reasoned that such newly arising cells would have the properties of CSCs. We therefore transformed HME and HME-flopc cells, by the sequential introduction of the SV40 early region (SV40-ER) and the H-ras oncogenes according to an established protocol (13) . In the text that follows, cells expressing hTERT and SV40-ER are denoted with the suffix LE (e.g., "HMLE-flopc"), and those expressing all three introduced genes-hTERT, SV40-ER, and Ras-are denoted with the suffix LER (e.g., "HMLER-flopc").
We determined that HMLE-flopc-CD44 lo cells converted into the CD44 hi state more efficiently than the nontransformed HMEflopc population. Moreover, HMLER-flopc-CD44 lo cells converted into the CD44 hi state at an even higher rate (Fig. 2C) . Like their nontransformed HME-CD44 lo counterparts, HMLER-CD44 lo cells displayed minimal interconversion ability (Fig. 2C ). We developed a simple proliferation-switching model (SI Materials and Methods) to determine the rate of conversions of CD44 lo cells into the CD44 hi state (shown schematically in Fig.  2A) , by using the proliferation rates (k i ) of purified CD44 lo and CD44 hi cells and the percentage of spontaneously arising CD44 hi cells (k s ) from each population over a 12-d period ( Fig. 2 B and C) . HME-flopc-CD44 such, conversion was increased twofold by the addition of SV40-ER alone and fivefold by the addition of SV40-ER plus Ras, relative to nontransformed HME-flopc cells. Hence, the sequential addition of SV40-ER and Ras progressively lowered the barriers to spontaneous conversion.
Spontaneous Generation of Cancer Stem-Like Cells in Vivo. To determine whether transformed CD44 lo cells could spontaneously dedifferentiate into CD44 hi -CSCs in vivo, we injected FACSpurified cells expressing pLV-Tomato s.c. into NOD/SCID mice; the injected cells were HMLER-CD44 lo (purified CD44 lo cells from the oncogenic counterparts of HME cells, which convert poorly to the CD44 hi state in 2D culture), FL2-LER-CD44 lo cells (purified CD44 lo cells from the oncogenic counterpart of clone FL2, which convert efficiently to the CD44 hi state in 2D culture), or the bulk FL2-LER population (the bulk oncogenic counterpart of clone FL2 containing both CD44 hi and CD44 lo cells). After 8-10 wk, tumors were removed, digested, and analyzed by FACS for CD44 status in the tomato-positive tumor cell population (Fig. 5A) Characteristics of Tumors Generated by Transformed Progenitor and Differentiated Epithelial Cells. Breast carcinoma is a heterogeneous collection of diseases whose diversity may be explained by the biology of the respective cells-of-origin from which these tumors arise (8, 9) . We thus compared the tumorigenicity of transformed derivatives of the HME bulk population (HMLER), of the HMEflopc bulk population (HMLER-flopc), of two HME-flopc-CD44 lo SCCs (FL1-LER and FL2-LER), and of two stable HME-flopc-CD44
hi SCCs (FH1-LER and FH2-LER). Importantly, the morphological differences that distinguished the untransformed precursors of these various cell populations were maintained in the respective transformed derivative populations and the in vitro proliferation rates of these various transformed cell populations were not significantly different (Fig. S4) .
We implanted 5 × 10 5 cell aliquots of the various RAS-transformed cell populations orthotopically into NOD/SCID mice. Cell populations with more differentiated cell phenotypes (HMLER, HMLER-flopc, F1-LER, and F2-LER) were on average poorly tumorigenic (25%, 50%, 80%, and 30% incidences, respectively), with well-differentiated tumor morphologies, whereas cell lines with a normal mammary stem-like phenotype (FH1-LER and FH2-LER) were highly tumorigenic (100% incidence) with poorly differentiated tumor morphologies (Fig. S5) . Limiting dilution analysis of the highly tumorigenic FH1-LER and FH2-LER cell populations determined the frequencies of tumor-initiating cells to be 1:1,420 and 1:1,804, respectively (determined by extreme limiting dilution analysis) (23) (Fig. S5E) . We estimate these frequencies to be at least 1,000 times greater than the tumor-initiating frequency of the other RAS-transformed cell populations tested here.
The CSC phenotype of the different CD44 hi cell populations was assessed in vitro by assessing tumorsphere-forming ability, where only CSC-derived tumorspheres have the ability to be serially passaged (11, 24) . HMLER cells, containing a very low CD44 hi component, formed low numbers of primary tumorspheres and could not be serially passaged, whereas de novoderived and preexisting CD44 hi cells efficiently formed primary, secondary, and tertiary tumorspheres (Fig. S5D) .
Together these observations demonstrate that oncogenic transformation of mammary stem-like cells yields more aggressive tumors than does oncogenic transformation of differentiated mammary epithelial cells and provide further evidence that the biological state of normal cells-of-origin before transformation strongly influences the behavior of their descendants following transformation (8, 25) .
Discussion
The most unanticipated discovery that has emerged from this study is the plasticity that we can now ascribe to human mammary epithelial cells. We have shown that differentiated mammary epithelial cells can convert to a stem-like state, doing so in an apparent stochastic manner in vitro. This conversion occurs in transformed and nontransformed HMECs isolated from cell lines and primary tissue. In each case, the conversion proceeded without genetic manipulation.
These findings represent a profound divergence from the currently accepted unidirectional hierarchical model of mammary epithelial cells and have widespread implications for the use of cultured cells. In mammalian cells, the idea that nonstem cells dedifferentiate to form functional stem cells has been restricted to the notion that progenitor cells can reacquire stem cell activity in mouse differentiating spermatogonia (26) . As such, our work demonstrates in mammalian cells that differentiated epithelial cells can revert to a stem-like state.
Our findings also hold implications for the development of anticancer therapeutics. As we previously reported, cells that have been forced experimentally into a mesenchymal/stem-like state can be used to screen for candidate therapeutic agents that specifically target CSCs (27) ; the intent here was to eliminate these cells and thereby deprive tumors of their ability to regenerate and thrive following initial therapy. However, if nonCSCs can spontaneously dedifferentiate into CSCs, then targeting CSC populations will, on its own, be unlikely to yield durable clinical responses, because the therapeutic eradication of existing CSC populations might be followed by their regeneration from non-CSCs within the tumor under treatment. Given the present findings, the known ability of microenvironmental signals to provoke epithelial-mesenchymal transitions (EMTs) and the close connection between passage through an EMT and entrance into a stem-cell state, we suspect that the presently observed spontaneous conversion in vitro may be augmented in vivo by contextual signals in the tumor microenvironment, such as those that drive the EMT (28, 29) . Relevant here are studies demonstrating that hypoxia-inducible factors (HIFs) can induce the EMT phenotype and promote metastasis and the CSC phenotype (30, 31) . Spontaneous dedifferentiation in vivo may involve the reactivation of one or more of the described pluripotency factors (Oct4, Klf4, c-myc, and Sox-2) (32). Hence, the representation of CSCs within tumor cell populations is likely to be influenced both by contextual signals and by the intrinsic phenotypic plasticity of these cells, as observed here.
A B
The ability of non-CSCs to convert into CSCs in vivo might resolve many of the current inconsistencies of the CSC model. In particular, the observed plasticity that was once reserved for CSCs alone can now be associated with nonstem cells. As such, CSC populations may differ profoundly between various tumor types according to the inherent plasticity of cells in their respective nonstem fractions and their ability to spawn CSCs de novo.
The present observations lend further support to the emerging view that the biological state of cells-of-origin is an important determinant of the phenotype of their transformed derivatives (8, 9) , where experimental transformation of cells that have a phenotype related to that of mammary stem cells generates cell populations with a high frequency of tumor-initiating cells (∼1:1,420-1:1,804 cells) and metastasis, which contrasts with the low tumor-initiating ability and nonmetastatic nature of tumors derived via transformation of more differentiated cell types.
The present findings hold the implication that patient-and tissue-specific stem-like cells may one day be created in vitro via spontaneous conversion of a patient's own terminally differentiated epithelial cells, a process that would not require any genetic alteration of these cells. Such stem-like cells could be important for regenerative therapies. Our results further emphasize the pathological implications of cellular plasticity in cancer development, progression, and recurrence. Further research needs to be undertaken to determine the mechanism underlying the de novo generation of CSCs from non-CSCs in vivo, with the promise of potential novel targets for future cancer therapies aimed at eradicating CSCs.
Materials and Methods
Detailed materials and methods are provided in SI Materials and Methods.
Cell Culture. HME cells and all derivatives were cultured in MEGM media as previously described (13) . HMECs were isolated from primary tissue as previously described (33) and cultured in M87A+X (34) . A list of antibodies is provided in Table S1 .
Mammosphere Culture. Mammosphere culture was performed as previously described (17) .
Flow Cytometry. Cells were prepared according to standard protocols.
Animal Studies. Athymic female nude mice were 2-4 mo of age at time of injections. Tumor cells were resuspended in 10% Matrigel/MEGM (20 μL) for mammary fat pad injections. GFP-positive lung metastases were counted from individual lobes by fluorescent microscopy.
Statistical Analysis. Data are presented as mean ± SEM. Student's t test (twotailed) was used to compare two groups (P < 0.05 was considered significant) unless otherwise indicated.
